@FierceMedDev: Special Report: 'Big' med tech M&A deals getting smaller. Feature | Follow @FierceMedDev
@DamianFierce: VisionCare landed up to $15M to market its AMD-treating eye implant. News | Follow @DamianFierce
@MarkHFierce: The U.S. will now have the first permanent implant designed to treat enlarged prostates. Expect a gradual launch. ICYMI yesterday | Follow @MarkHFierce
@MichaelGFierce: Abbott snags CE mark for diabetes monitor. Item | Follow @MichaelGFierce
> Boston Scientific ($BSX) reported solid 6-month results for its Lotus device, the company's entrée into transcatheter aortic valve replacement. More
> Salt Lake City's Vital Access scored FDA clearance for its VWing Vascular Needle Guide, designed for hemodialysis procedures. News
> Philips ($PHG) has raised financial targets for most of its units, counting on its banner medical device business to deliver between 4% and 6% sales growth. Article
> In nonrandomized trials, renal denervation has demonstrated significant reductions in blood pressure among hypertensive patients, but those results are likely to come back down to earth in a randomized study, some researchers say. Story
> JenaValve in Germany nailed down an expanded CE mark to use its transcapical TAVI system to treat aortic regurgitation. More
> SpineGuard landed Japanese regulatory approval for a new handheld surgical product that helps guide proper spine screw placement. Item
> The Mayo Clinic is celebrating its 1,000th cochlear implant over 30 years. Item
Biotech News
@FierceBiotech: ICYMI yesterday: CDC director warns antibiotics pipeline 'nearly empty.' Story | Follow @FierceBiotech
@JohnCFierce: Regado CEO moves the goal line after a rare biotech IPO misfire. More | Follow @JohnCFierce
> Biotechs keep the cash pumping (for now) with more IPOs and ATMs. Story
> On a roll, Boehringer wins 'breakthrough' status for pioneering leukemia drug. News
> Broker's Facebook rant on biotech stock draws $5K fine. Item
Pharma News
@FiercePharma: Now armed with EU nod for Lemtrada, Sanofi preps to launch its multiple sclerosis duo (with Aubagio). Release (PDF) | Follow @FiercePharma
@CarlyHFierce: Whistleblower codenamed Zorro implicates Novartis' Alcon division in Chinese bribery scandal. More from The Financial Times | Follow @CarlyHFierce
> Novartis faces second set of bribery claims in China. More
> FDA approves Teva's generic of Roche blockbuster Xeloda. Article
Pharma Manufacturing News
@EricPFierce: Now that Ranbaxy's Mohali plant falls under FDA consent decree, oversight ramps up significantly. Article | Follow @EricPFierce
> Cargill invests $15M in French alginate plant. Item
> Hospira recalls bupivacaine because of steel particles in vials. Story
> Strides gets FDA warning for plant Mylan is buying. More
> J&J sues Ben Venue over Doxil shortage. Report
Biotech Research News
@EmilyMFierce: Initial focus of BRAIN Initiative laid out, but are the goals any clearer than they were in April? Check out the story and weigh in | Follow @EmilyMFierce
> Visterra antibody shows promise in preclinical study as universal flu vaccine. Item
> NIH partners with Eli Lilly, others on rare diseases. Article
> Experimental vaccine clears monkeys of HIV-like virus. More
> Genia Technologies, Columbia, Harvard nab $5.3M NIH grant for genome sequencing. Story